PB2206: PROGRESSION FACTORS OF MYELOFIBROSIS BASED ON CLINICAL FEATURES AND NEXT-GENERATION SEQUENCING LANDSCAPE OF ESSENTIAL THROMBOCYTHEMIA: A CHINES TWO-CENTER RETROSPECTIVE STU...

por Xiang, Danhong, Hu, Shiwei, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Feng, Qiutian, Huang, Jian
Publicado 2023

P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIEN...

por Feng, Qiutian, Hu, Shiwei, Xiang, Danhong, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Zhu, Xiaoqiong, Huang, Jian
Publicado 2023

Worldwide cancer statistics of adults over 75 years old in 2019: a systematic analysis of the global burden of disease study 2019

por Xiang, Danhong, Hu, Shiwei, Mai, Tianxiang, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Jin, Keyi, Huang, Jian
Publicado 2022

The mechanisms and cross-protection of trained innate immunity

por Hu, Shiwei, Xiang, Danhong, Zhang, Xinlu, Zhang, Lan, Wang, Shengjie, Jin, Keyi, You, Liangshun, Huang, Jian
Publicado 2022

PB2211: DIFFERENCES IN POST-POLYCYTHEMIA VERA AND POST–ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS VS PRIMARY MYELOFIBROSIS IN FIBROTIC STAGE: A RETROSPECTIVE, REAL-WORLD STUDY CONDUCT...

por Wang, Shengjie, Zhang, Lan, Jin, Keyi, Hu, Shiwei, Zhang, Xinlu, Xiang, Danhong, Feng, Qiutian, Tu, Lingrong, Jin, Jie, Huang, Jian
Publicado 2023